The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?

The endocannabinoid system (ECS) has been placed in the anti-cancer spotlight in the last decade. The immense data load published on its dual role in both tumorigenesis and inhibition of tumor growth and metastatic spread has transformed the cannabinoid receptors CB1 (CB1R) and CB2 (CB2R), and other...

Descrición completa

Detalles Bibliográficos

Principais autores:	Estefanía Moreno, Milena Cavic, Ana Krivokuca, Vicent Casadó, Enric Canela
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2019-04-01
Series:	Frontiers in Pharmacology
Assuntos:	endocannabinoids G protein-coupled receptor cannabinoid CB1 receptor cannabinoid CB2 receptor ethical issues marijuana legalization
Acceso en liña:	https://www.frontiersin.org/article/10.3389/fphar.2019.00339/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!